Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance Through Mixed Chimerism (Sip-Tego)

NCT06972069 is registered in ClinicalTrials.gov with Tatsuo Kawai, MD, PhD as lead sponsor.

NCT NCT06972069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06972069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance Through Mixed Chimerism (Sip-Tego)
Lead sponsor
Tatsuo Kawai, MD, PhD
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 31, 2025
Completion date
December 31, 2030
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunosuppresion, immunosuppression after kidney transplantation, kidney failure, transplant recipient (kidney), transplant tolerance